Newest NIH notices and announcements, note this list will be updated weekly so please check back for more NIH funding opportunities.
Click HERE to find previous NIH funding lists
|
Opportunity # |
Title |
Deadline |
|
Notice to Extend PA-16-453 " AHRQ Conference Grant Programs (R13)" |
|
|
|
Notice of Change to the Expiration Date and the Last Receipt Date of PAR-19-287, "Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)" |
|
|
|
Notice to Extend the Expiration Date of PAR-18-877 "Early Stage Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)" |
|
|
|
Notice to Extend the Expiration Date of PAR-18-878 "Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)" |
|
|
|
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) |
September 28, 2023 |
|
|
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed) |
November 19, 2021 |
|
|
PAR-22-027 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
September 7, 2021 |
|
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
November 12, 2021 |
|
|
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed) |
March 3, 2022 |
|
|
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) |
September, 7, 2024 |
|
|
RFA-DK-21-503 [Related Opportunities] |
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
November 30, 2021 |
|
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) Department of Health and Human Services |
December 9, 2021 |
|
|
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) |
November 11, 2021 |
|
|
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
September 10, 2024 |
|
|
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed) |
November 10, 2021 |
|
|
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed) |
October 22, 2021 |
|
|
Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) |
November 22, 2021 |
|
|
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) |
February 22, 2024 |
|
|
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed) |
October 20, 2021 |
|
|
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) |
September 7, 2024 |
|
|
Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) |
October 20, 2021 |
|
|
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
September 7, 2023 |
|
|
Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) |
January 7, 2025 |
|
|
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) |
October 6, 2022 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
June 15, 2023 |
|
|
Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
October 22, 2021 |
|
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
June 15, 2023 |
|
|
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
May 7, 2023 |
|
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) |
May 26, 2025 |
|
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
October 19, 2021 |
|
|
Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) |
October 20, 2021 |
|
|
Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed) |
February 2, 2022 |
|
|
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) |
September 7, 2024 |
|
|
Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) |
October 15, 2021 |
|
|
Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional) |
October 13, 2021 |
|
|
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
March 11, 2024 |
|
|
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
September 7, 2024 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
March 4, 2024 |
|
|
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) |
March 4, 2024 |
|
|
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) |
October 4, 2021 |
|
|
High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) |
October 28, 2021 |
|
|
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
October 10, 2023 |
|
|
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) |
September 9, 2021 |
|
|
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) |
August 8, 2024 |
|
|
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) |
October 14, 2021 |
|
|
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
July 13, 2023 |
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) |
May 7, 2024 |
|
|
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
February 28, 2024 |
|
|
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) |
May 7, 2024 |
|
|
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
May 7, 2024 |
|
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
February 20, 2024 |
|
|
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) |
October 20, 2021 |
|
|
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
May 7, 2025 |
|
|
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) |
January 6, 2022 |
|
|
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) |
February 20, 2024 |
|
|
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed) |
September 24, 2021 |
|
|
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
|
May 7, 2024 |
|
|
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) |
January 6, 2022 |
|
|
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
July 12, 2022 |
|
|
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
June 21, 2023 |
|
|
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
March 16, 2024 |
|
|
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
January 10, 2024 |
|
|
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) |
October 4, 2021 |
|
|
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
July 6, 2023 |
|
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) |
March 9, 2022 |
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) |
February 15, 2024 |
|
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) |
February 15, 2024 |
|
|
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) |
May 25, 2023 |
|
|
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
April 13, 2023 |
|
|
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
January 7, 2024 |
|
|
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) |
September 15, 2021 |
|
|
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
September 27, 2023 |
|
|
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
May 25, 2023 |
|
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
May 7, 2024 |
|
|
NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) |
September 15, 2021 |
|
|
nstitutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) |
September 25, 2023 |
|
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) |
January 7, 2024 |
|
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
January 7, 2024 |
|
|
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
January 7, 2024 |
|
|
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
February 15, 2024 |
|
|
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
July 25, 2023 |
|
|
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
October 26, 2023 |
|
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
October 17, 2023 |
|
|
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
January 7, 2024 |
|
|
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
September 7, 2023 |
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
June 15, 2022 |
|
|
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) |
November 16, 2022 |
|
|
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
June 15, 2022 |
|
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
December 2, 2022 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
September 7, 2023 |
|
|
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
March 10, 2022 |
|
|
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) |
March 7, 2023 |
|
|
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
February 24, 2023 |
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
October 10, 2023 |
|
|
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
September 13, 2023 |
|
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
July 23, 2023 |
|
|
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
January 7, 2023 |
|
|
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
March 27, 2023 |
|
|
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
December 14, 2021 |
|
|
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
June 13, 2023 |
|
|
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) [Related Opportunities] |
January 18, 2022 |
|
|
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) |
May 17, 2023 |
|
|
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) |
December 7, 2023 |
|
|
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) |
September 7, 2023 |
|
|
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
November 17, 2021 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
July 20, 2022 |
|
|
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed) |
October 21, 2022 |
|
|
Research to Improve Native American Health (R21 Clinical Trials Optional) |
September 7, 2023 |
|
|
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) |
September 7, 2023 |
|
|
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
July 14, 2023 |
|
|
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
November 9, 2022 |
|
|
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
April 15, 2022 |
|
|
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
November 28, 2023 |
|
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
November 17, 2022 |
|
|
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
May 30, 2023 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
May 7, 2023 |
|
|
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
November 15, 2023 |
|
|
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
September 7, 2022 |
|
|
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) |
September 7, 2023 |
|
|
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) |
July 8, 2023 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) |
March 13, 2023 |
|
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) |
March 13, 2023 |
|
|
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) |
March 17, 2023 |
|
|
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
May 7, 2023 |
|
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
May 7, 2023 |
|
|
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) |
May 7, 2023 |
|
|
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
May 7, 2023 |
|
|
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) |
May 7, 2023 |
|
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
May 21, 2023 |
|
|
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) |
May 7, 2023 |
|
|
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
May 7, 2023 |
|
|
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) |
July 14, 2022 |
|
|
Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
March 27, 2023 |
|
|
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
July 28, 2022 |
|
|
PAR-20-150 |
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
June 16, 2023 |
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
May 7, 2023 |
|
|
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
May 7, 2023 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: February 9, 2022, August 9, 2022, February 9, 2023 |
|
|
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) |
LOI due: 30 days prior to app due date App due: March 9, 2022 |
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
LOI due: 30 days prior to app due date App due: February 9, 2022, August 9, 2022, February 9, 2023 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
LOI due: October 26, 2021; February 25, 2022 App due: November 26, 2021; March 25, 2022 |
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Substance Use Disorders, or Alcohol Use Disorder (U19 Clinical Trial Optional) |
LOI due: October 26, 2021; February 25, 2022 App due: November 26, 2021; March 25, 2022 |
|
|
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30 Clinical Trial Optional |
May 27, 2022 |
|
|
|
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
September 28, 2021 January 26, 2022 May 26, 2022 September 27, 2022 |
|
|
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional |
LOI due 30 days prior to app due date: April 3, 2022 |
|
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
October 28, 2021 February 26, 2022 October 28, 2022 |
|
|
Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: November 3, 2021 |
|
|
|
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: November 3, 2021 |
|
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
LOI due 30 days prior to app due date: November 3, 2021 |
|
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
LOI due 30 days prior to app due date: November 3, 2021 |
|
|
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
September 1, 2022 |
|
|
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
January 11, 2022 June 10, 2022 |
|
Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
January 27, 2022 |
|
|
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32) |
LOI due dates: August 26, 2022 App due dates: September 27, 2021; September 26, 2022 |
|
|
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Independent Clinical Trial Not Allowed) |
LOI due dates: August 25, 2022 App due dates: September 27, 2021; September 26, 2022 |
|
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) |
October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022 |
|
|
Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed) |
January 25, 2022; May 25, 2022 |
|
|
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
March 30, 2022 |
|
|
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) |
October 6, 2021 |
|
|
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32Clinical Trial Not Allowed) |
October 14, 2021, February 9, 2022, June 8,2022, and October 11, 2022 |
|
|
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
November 30, 2021 |
|
|
Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) |
November 30, 2021 |
|
|
Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) |
November 30, 2021 |
|
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
November 17, 2021, March 17, 2022, July 19, 2022, November 7, 2022 |
|
|
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) |
September 15, 2021, September 15, 2022 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 |
|
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 |
|
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 |
